Table 1: Rates of early stage CTCL response to NB-UVB phototherapy in relation to duration and dose of NB-UVB.

Complete remissionPartial remission

Patients: % (number)76.4% (21/27)23.6% (6/27)
Duration of treatment in weeks:
range (mean)
5–14 (12.7)14
No. of sessions:
range (mean)
15–42 (28.9)42
Cumulative NB-UVB dose in J/cm2:
range (mean)
17.3–48.2 (38.7)45.7–48.2 (46.6)
Maintenance of remission: % (number)42.8% (9/21)N.A.